Literature DB >> 31482384

Infant Mortality in Moscow: the Perils of Progress in Russia's World City.

Irina B Grafova1, Michael K Gusmano2, Karen Martirosyan3, Daniel Weisz4, Victor G Rodwin3.   

Abstract

This paper examines changes in infant mortality (IM) in Moscow, Russia's largest and most affluent city. Along with some remarkable improvements in Moscow's health system over the period between 2000 and 2014, the overall IM rate for Moscow's residents decreased substantially between 2000 and 2014. There remains, however, substantial intra-city variation across Moscow's 125 neighborhoods. Our regression models suggest that in higher-income neighborhoods measured by percent of population with rental income as a primary source, the IM rate is significantly lower than in lower-income neighborhoods measured by percent of population with transfer income as primary source (housing and utility subsidies and payments to working and low-income mothers, single mothers and foster parents). We also find that the density of physicians in a neighborhood is negatively correlated with the IM rate, but the effect is small. The density of nurses and hospital beds has no effect. We conclude that overall progress on health outcomes and measures of access does not, in itself, solve the challenge of intra-urban inequalities.

Entities:  

Keywords:  Infant mortality; Intra-city health inequalities; Moscow

Mesh:

Year:  2019        PMID: 31482384      PMCID: PMC6904694          DOI: 10.1007/s11524-019-00375-z

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  21 in total

1.  Money for health in Russia, at long last.

Authors:  Ben Aris
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

2.  Measuring the health of nations: updating an earlier analysis.

Authors:  Ellen Nolte; C Martin McKee
Journal:  Health Aff (Millwood)       Date:  2008 Jan-Feb       Impact factor: 6.301

3.  The use of medical care and out-of-pocket payments in Russia.

Authors:  Liudmila Zasimova
Journal:  Scand J Public Health       Date:  2016-03-15       Impact factor: 3.021

4.  Infant mortality and income in 4 world cities: New York, London, Paris, and Tokyo.

Authors:  Victor G Rodwin; Leland G Neuberg
Journal:  Am J Public Health       Date:  2005-01       Impact factor: 9.308

5.  To what extent do biomarkers account for the large social disparities in health in Moscow?

Authors:  Dana A Glei; Noreen Goldman; Vladimir M Shkolnikov; Dmitri Jdanov; Svetlana Shalnova; Maria Shkolnikova; Maxine Weinstein
Journal:  Soc Sci Med       Date:  2012-11-27       Impact factor: 4.634

6.  Measuring progress in meeting healthy people goals for low birth weight and infant mortality among the 100 largest cities and their suburbs.

Authors:  Lisa M Duchon; Dennis P Andrulis; Hailey M Reid
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

7.  Understanding social disparities in hypertension prevalence, awareness, treatment, and control: the role of neighborhood context.

Authors:  Jeffrey D Morenoff; James S House; Ben B Hansen; David R Williams; George A Kaplan; Haslyn E Hunte
Journal:  Soc Sci Med       Date:  2007-07-20       Impact factor: 4.634

8.  Paediatrics in Russia: past, present and future.

Authors:  Alexander Baranov; Leyla Namazova-Baranova; Valery Albitsky; Natalia Ustinova; Rimma Terletskaya; Olga Komarova
Journal:  Arch Dis Child       Date:  2017-06-13       Impact factor: 3.791

9.  Vulnerability to food insecurity in urban slums: experiences from Nairobi, Kenya.

Authors:  E W Kimani-Murage; L Schofield; F Wekesah; S Mohamed; B Mberu; R Ettarh; T Egondi; C Kyobutungi; A Ezeh
Journal:  J Urban Health       Date:  2014-12       Impact factor: 3.671

10.  City-Specific Spatiotemporal Infant and Neonatal Mortality Clusters: Links with Socioeconomic and Air Pollution Spatial Patterns in France.

Authors:  Cindy M Padilla; Wahida Kihal-Talantikit; Verónica M Vieira; Séverine Deguen
Journal:  Int J Environ Res Public Health       Date:  2016-06-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.